The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro

Besides its cardiotoxic effect, doxorubicin also elicits inflammatory effects in vivo. 7-Monohydroxyethylrutoside (monoHER) has recently been used as a protector against doxorubicin-induced cardiotoxicity in vivo. It is not known yet whether monoHER can also protect against doxorubicin-induced infla...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Abou El Hassan, M A I, Verheul, H M W, Jorna, A S, Schalkwijk, C, van Bezu, J, van der Vijgh, W J F, Bast, A
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2003
Предметы:
Experimental Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394271/
https://ncbi.nlm.nih.gov/pubmed/12865930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601022
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы